LinkedIn Profile

Access Accelerate Diagnostics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:axdx 2921028 Apr 21st, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 20th, 2024 10:59PM Apr 20th, 2024 10:59PM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 20th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 19th, 2024 10:58PM Apr 20th, 2024 04:37PM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 19th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 18th, 2024 11:07PM Apr 18th, 2024 11:07PM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 18th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 17th, 2024 11:04PM Apr 18th, 2024 05:57PM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 17th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 16th, 2024 10:50PM Apr 17th, 2024 02:21PM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 16th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 15th, 2024 10:45PM Apr 16th, 2024 10:37AM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 15th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 14th, 2024 10:46PM Apr 15th, 2024 04:18PM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 14th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 13th, 2024 10:39PM Apr 13th, 2024 10:39PM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 13th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 12th, 2024 10:30PM Apr 13th, 2024 11:05AM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology
nasdaq:axdx 2921028 Apr 12th, 2024 12:00AM Accelerate Diagnostics 9.8K 129.00 Open Apr 11th, 2024 10:33PM Apr 12th, 2024 08:00AM Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier. Open Diagnostics, Medical Devices, and Microbiology Open 3950 South Country Club Road Tucson AZ US 85714 Accelerate Diagnostics Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.